Invesco Nasdaq Biotechnology ETF (IBBQ) Price, Holdings, & News

Invesco Nasdaq Biotechnology ETF's stock was trading at $21.89 at the beginning of 2024. Since then, IBBQ stock has decreased by 7.1% and is now trading at $20.33.
View the best growth stocks for 2024 here.

Invesco Nasdaq Biotechnology ETF saw a increase in short interest in March. As of March 31st, there was short interest totaling 8,200 shares, an increase of 4,000.0% from the March 15th total of 200 shares. Based on an average daily volume of 20,900 shares, the short-interest ratio is presently 0.4 days.
View Invesco Nasdaq Biotechnology ETF's Short Interest.

Invesco Nasdaq Biotechnology ETF announced a quarterly dividend on Friday, March 15th. Investors of record on Tuesday, March 19th will be paid a dividend of $0.0435 per share on Friday, March 22nd. This represents a $0.17 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date of this dividend is Monday, March 18th.
Read our dividend analysis for IBBQ.

Invesco Nasdaq Biotechnology ETF is a equity fund issued by Invesco. IBBQ focuses on health care investments and follows the Nasdaq Biotechnology Index. The fund's investments total to approximately $29.84 million assets under management.

IBBQ invests in 220 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), AstraZeneca (AZN), Biogen (BIIB), Moderna (MRNA), Seagen (SGEN), Illumina (ILMN) and Horizon Therapeutics Public (HZNP).

Invesco Nasdaq Biotechnology ETF's management fee is 0.19% and has no other recorded expenses or fee waivers. The net expense ratio for IBBQ is 0.19%.

Shares of IBBQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.